Cellular expression of beta-microseminoprotein (β-MSP) mRNA and its protein in untreated prostate cancer

Prostate

Volumn 35, Issue 2, 1998, Pages 109-116

  Tsurusaki, Toshifumi ^a   Koji, Takehiko ^a   Sakai, Hideki ^a   Kanetake, Hiroshi ^a   Nakane, Paul K ^a   Saito, Yutaka ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Beta microseminoprotein; Immunohistochemistry; In situ hybridization; Prostate cancer

Indexed keywords

BETA MICROSEMINOPROTEIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PEPTIDES; PROSTATIC NEOPLASMS; PROSTATIC SECRETORY PROTEINS; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0031921229     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980501)35:2<109::AID-PROS4>3.0.CO;2-E     Document Type: Article

References (30)

1. Mbikay M, Nolet S, Fournier S, Benjannet S, Chapdelaine P, Paradis G, Dube JY, Tremblay R, Lazure C, Seidah NG, Chrétien M: Molecular cloning and sequence of the cDNA for a 94-amino-acids seminal plasma protein secreted by the human prostate. DNA 1987;6:23-29.
2. Seidah NG, Arbatti NJ, Rochemont J, Sheth AR, Chrétien M: Complete amino acid sequence of human seminal plasma β-inhibin. FEBS Lett 1984;175:349-355.
3. Akiyama K, Yoshioka Y, Schmid K, Offner GD, Troxler RF, Tsuda R, Hara M: The amino acid sequence of human β-microseminoprotein. Biochim Biophys Acta 1985;829:288-294.
4. Sasaki T, Matsumoto N, Jinno Y, Niikawa N, Sakai H, Kanetake H, Saito Y: Assignment of the human β-microseminoprotein gene (MSMB) to chromosome 10q11.2. Cytogenet Cell Genet 1996;72:177-178.
5. Ulvsbäck M, Lindström C, Weiber H, Abrahamsson PA, Lilja H, Lundwall A: Molecular cloning of a small prostate protein, known as β-microseminoprotein, PSP94 or β-inhibin, and demonstration of transcripts in non-genital tissues. Biochem Biophys Res Commun 1989;164:1310-1315.
6. Liu AY, Bradner RC, Vessella RL: Decreased expression of prostatic secretory protein PSP94 in prostate cancer. Cancer Lett 1993;74:91-99.
7. Green CB, Liu WY, Kwok SCM: Cloning and nucleotide sequence analysis of the human β-microseminoprotein gene. Biochem Biophys Res Commun 1990;167:1184-1190.
8. Nolet S, Mbikay M, Chrétien M: Prostatic secretory protein PSP94: Gene organization and promoter sequence in rhesus monkey and human. Biochim Biophys Acta 1991;1089:247-249.
9. Ulvsbäck M, Spurr NK, Lundwall Å: Assignment of the human gene for β-microseminoprotein (MSMB) chromosome 10 and demonstration of related genes in other vertebrates. Genomics 1991;11:920-924.
10. Garde SV, Sheth AR, Porter AT, Pienta KJ: A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines. Cancer Lett 1993; 70:159-166.
11. Teni TR, Sheth AR, Kamath MR, Sheth NA: Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate. Cancer Lett 1988;43:9-14.
12. Kharbanda K, Duraiswami S: Further studies on the synthesis and secretion of inhibin-like material by rat ventral prostate explants in vitro. Prostate 1990;16:163-172.
13. Sheth AR, Teni TR, Sheth NA: Human prostatic inhibin. In Imura H (ed): "Progress in Endocrinology." Amsterdam: Elsevier Science Publishers BV, 1988:301-306.
14. Doctor VM, Sheth AR, Simha MM, Arbatti NJ, Aaveri JP, Sheth NA: Studies on immunohistochemical localization of inhibin-like material in human prostate tissue: Comparison of its distribution in normal, benign and malignant prostates. Br J Cancer 1986;53:547-554.
15. Brar A, Mbikay M, Sirois F, Fournier S, Seidah NG, Chrétien M: Localization of the human prostatic secretory protein PSP94 and its mRNA in the epithelial cells of the prostate. J Androl 1988; 9:253-260.
16. Hyakutake H, Sakai H, Yogi Y, Tsuda R, Minami Y, Yushita Y, Kanetake H, Nakazono I, Saito Y: Beta-microseminoprotein immunoreactivity as a new prognostic indicator of prostate carcinoma. Prostate 1993;22:347-355.
17. Yogi Y: A monoclonal antibody assessment of the beta-microseminoprotein expression in prostatic carcinoma as a prognostic indicator. Acta Med Nagasaki 1995;40:13-17.
18. Mundle SD, Sheth NA: Suppression of DNA synthesis and induction of apoptosis in rat prostate by human seminal plasma inhibin (HSPI). Cell Biol Int 1993;17:587-594.
19. Garde S, Sheth A, Porter AT, Pienta KJ: Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and in vivo. Prostate 1993;22:225-233.
20. Lokeshwar BL, Hurkadli KS, Sheth AR, Block NL: Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor. Cancer Res 1993;53:4855-4859.
21. Xuan JW, Chin JL, Guo Y, Chambers AF, Finkelman MA, Clarke MW: Alternative splicing of PSP94 (prostatic secretory protein of 94 amino acids) mRNA in prostate tissue. Oncogene 1995;11: 1041-1047.
22. Koji T, Nakane PK: Recent advances in molecular histochemical techniques: In situ hybridization and Southwestern histochemistry. J Electron Microsc (Tokyo) 1996;45:119-127.
23. Gleason DF: Histologic grading and clinical staging of prostatic carcinoma. In Tannenbaum M (ed): "Urologic Pathology: The Prostate." Philadelphia: Lea & Febiger, 1977:171-198.
24. Adams JC: Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 1981;29:775.
25. Koji T, Brenner RM: Localization of estrogen receptor messenger ribonucleic acid in rhesus monkey uterus by nonradioactive in situ hybridization with digoxigenin-labeled oligodeoxynucleotides. Endocrinology 1993;132:382-392.
26. Yoshii A, Koji T, Ohsawa N, Nakane PK: In situ localization of ribosomal RNAs in a reliable reference for hybridizable RNA in tissue sections. J Histochem Cytochem 1995;43:321-327.
27. Carter BS, Ewing CM, Ward WS, Treiger BF, Aaldeers TW, Schalken JA, Epstein JI, Issacs WB: Allelic loss of chromosomes 16p and 10q in human prostate cancer. Proc Natl Acad Sci USA 1990;87:8751-8755.
28. Bergerheim USR, Kunimi K, Collins VP, Ekman P: Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Gene Chrom Cancer 1991;3:215-220.
29. Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, Kastendieck H: Cytogenetic survey of 32 cancers of prostate. Cancer Genet Cytogenet 1993;66:93-99.
30. Shapiro DN, Valentine V, Eagle L, Yin X, Morris SW, Prochownik EV: Assignment of the human MAD and MXI1 genes to chromosomes 2p12→p13 and 10q24→q25. Genomics 1994;23: 282-285.